TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Daily Photo Galleries

Wednesday, June 4, 2014, 10:51 a.m.
 

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. 8 Western Pennsylvania hospitals penalized over infections
  2. Beacons track shoppers’ smartphones amid retailers’ aisles
  3. Nonprofit hospitals in Western Pa. feel pain in finances despite Affordable Care Act
  4. Hospital finances still crying ‘ouch’
  5. Online price battle heats up with intraday price fluctuations
  6. Ford expands air bag recall across U.S.
  7. Stock market makes biggest gain in 3 years
  8. Gas field drillers, activists seek statewide rules for wells
  9. Peet’s Coffee & Tea closes its 3 Pittsburgh stores
  10. Alcoa buying jet engine components maker Tital to help expand aerospace unit
  11. Natural gas groups says increase in Pennsylvania taxes would bring dire results for economy
Subscribe today! Click here for our subscription offers.